Chantix Dangerous Drug
A new study on Chantix done by the Public Health Sciences at Wake Forest Baptist Medical Center and published online in the Public Library of Science journal PLoS One, conflicts with recents studies done by the FDA.
<p class="i1">"Pfizer’s smoking cessation drug Chantix carries too many risks and should only be tried when other treatments fail, researchers said on Wednesday".<br />
<br />
"Chantix was eight times more likely to be linked with a reported case of suicidal behavior or depression than other nicotine replacement products, such as the nicotine patch, they said".</p>